ARDX Valuation

Ardelyx Inc

Add to Watchlist

Advanced Chart

6.360

-0.02(-0.313%)1D

Overview
Forecast
Valuation
Earnings

ARDX Relative Valuation

ARDX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ARDX is overvalued; if below, it's undervalued.

Historical Valuation

Ardelyx Inc (ARDX) is now in the Undervalued zone, suggesting that its current forward PS ratio of 3.56 is considered Undervalued compared with the five-year average of -11.82. The fair price of Ardelyx Inc (ARDX) is between 30.22 to 31.75 according to relative valuation methord. Compared to the current price of 6.36 USD , Ardelyx Inc is Undervalued By 78.96%.

Relative Value

Fair Zone

30.22-31.75

Current Price：6.36

78.96%

Undervalued

-32.09

Trailing

Forward

31.31

EV/EBITDA

Ardelyx Inc. (ARDX) has a current EV/EBITDA of 31.31. The 5-year average EV/EBITDA is -15.54. The thresholds are as follows: Strongly Undervalued below -92.72, Undervalued between -92.72 and -54.13, Fairly Valued between 23.04 and -54.13, Overvalued between 23.04 and 61.63, and Strongly Overvalued above 61.63. The current Forward EV/EBITDA of 31.31 falls within the Overvalued range.

-85.77

EV/EBIT

Ardelyx Inc. (ARDX) has a current EV/EBIT of -85.77. The 5-year average EV/EBIT is -16.37. The thresholds are as follows: Strongly Undervalued below -61.44, Undervalued between -61.44 and -38.90, Fairly Valued between 6.16 and -38.90, Overvalued between 6.16 and 28.69, and Strongly Overvalued above 28.69. The current Forward EV/EBIT of -85.77 falls within the Strongly Undervalued range.

3.56

Ardelyx Inc. (ARDX) has a current PS of 3.56. The 5-year average PS is 28.01. The thresholds are as follows: Strongly Undervalued below -79.70, Undervalued between -79.70 and -25.84, Fairly Valued between 81.86 and -25.84, Overvalued between 81.86 and 135.71, and Strongly Overvalued above 135.71. The current Forward PS of 3.56 falls within the Historic Trend Line -Fairly Valued range.

228.38

P/OCF

Ardelyx Inc. (ARDX) has a current P/OCF of 228.38. The 5-year average P/OCF is 68.28. The thresholds are as follows: Strongly Undervalued below -342.23, Undervalued between -342.23 and -136.97, Fairly Valued between 273.54 and -136.97, Overvalued between 273.54 and 478.80, and Strongly Overvalued above 478.80. The current Forward P/OCF of 228.38 falls within the Historic Trend Line -Fairly Valued range.

-250.36

P/FCF

Ardelyx Inc. (ARDX) has a current P/FCF of -250.36. The 5-year average P/FCF is -15.19. The thresholds are as follows: Strongly Undervalued below -184.16, Undervalued between -184.16 and -99.67, Fairly Valued between 69.30 and -99.67, Overvalued between 69.30 and 153.78, and Strongly Overvalued above 153.78. The current Forward P/FCF of -250.36 falls within the Strongly Undervalued range.

Ardelyx Inc (ARDX) has a current Price-to-Book (P/B) ratio of 10.97. Compared to its 3-year average P/B ratio of 7.74 , the current P/B ratio is approximately 41.75% higher. Relative to its 5-year average P/B ratio of 5.84, the current P/B ratio is about 87.81% higher. Ardelyx Inc (ARDX) has a Forward Free Cash Flow (FCF) yield of approximately -3.60%. Compared to its 3-year average FCF yield of -11.37%, the current FCF yield is approximately -68.32% lower. Relative to its 5-year average FCF yield of -36.18% , the current FCF yield is about -90.05% lower.

10.97

P/B

Median3y

7.74

Median5y

5.84

-3.60

FCF Yield

Median3y

-11.37

Median5y

-36.18

Competitors Valuation Multiple

The average P/S ratio for ARDX's competitors is 64.34, providing a benchmark for relative valuation. Ardelyx Inc Corp (ARDX) exhibits a P/S ratio of 3.56, which is -94.47% above the industry average. Given its robust revenue growth of 33.38%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

Travere Therapeutics Inc

Phibro Animal Health Corp

Viridian Therapeutics Inc

Performance Decomposition

Market capitalization of ARDX decreased by 7.69% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 73.22M to 97.66M.

The secondary factor is the Margin Expansion, contributed -13.04%to the performance.

Overall, the performance of ARDX in the past 1 year is driven by Revenue Growth. Which is more sustainable.

33.38%

73.22M → 97.66M

Revenue Growth

-13.04%

-22.47 → -19.54

Margin Expansion

-28.03%

-37.29 → -26.84

P/E Change

-7.69%